PlainRecalls
FDA Devices Moderate Class II Terminated

Edwards Lifesciences IntraClude Intra-Aortic Occlusion Device, model number ICF100, 10.5 Fr (3.5 mm) x 39.4" (100 cm) ThruPort System. Packaged sterile and non-pyrogenic in a sealed, peel-type pouch For use in patients undergoing cardiopulmonary bypass.

Reported: June 17, 2015 Initiated: May 5, 2015 #Z-1758-2015

Product Description

Edwards Lifesciences IntraClude Intra-Aortic Occlusion Device, model number ICF100, 10.5 Fr (3.5 mm) x 39.4" (100 cm) ThruPort System. Packaged sterile and non-pyrogenic in a sealed, peel-type pouch For use in patients undergoing cardiopulmonary bypass.

Reason for Recall

Potential device damage on the strain relief near the hub area, which may result in blood leakage.

Details

Recalling Firm
Edwards Lifesciences, LLC
Units Affected
3,360 units.
Distribution
Nationwide Distribution -- US, including the states of Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Kentucky, Louisiana, Massachusetts, Maine, Michigan, Missouri, Mississippi, North Carolina, Nebraska, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, and West Virginia.
Location
Draper, UT

Frequently Asked Questions

What product was recalled?
Edwards Lifesciences IntraClude Intra-Aortic Occlusion Device, model number ICF100, 10.5 Fr (3.5 mm) x 39.4" (100 cm) ThruPort System. Packaged sterile and non-pyrogenic in a sealed, peel-type pouch For use in patients undergoing cardiopulmonary bypass.. Recalled by Edwards Lifesciences, LLC. Units affected: 3,360 units..
Why was this product recalled?
Potential device damage on the strain relief near the hub area, which may result in blood leakage.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 17, 2015. Severity: Moderate. Recall number: Z-1758-2015.